Abstract: Positioning with a help of navigational aids data are considered as main backup method is used in civil aviation. Currently, the ground network of navigational aids is minimized to guarantee ...
In recent months, Vor Biopharma closed a US$424.83 million shelf registration, repriced employee stock options, and reported positive late-stage clinical data for its autoimmune drug candidate ...
Abstract: While the Global Navigation Satellite System (GNSS) has established as the predominant source for delivering high-precision and high-integrity services in numerous aeronautical applications, ...
Vor Biopharma (VOR) has jumped onto investors’ radar after strong Phase 3 data for telitacicept in IgA nephropathy, paired with upbeat new Wall Street coverage that frames the drug’s long term ...
Hosted on MSN
Vor Biopharma approves stock option repricing plan
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Vor Biopharma (VOR) rose ~17% on Tuesday after J.P. Morgan initiated its coverage with an Overweight recommendation and a Dec. 2026 price target of $43, citing a potential blockbuster status for the ...
Investing.com - JPMorgan has initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with an Overweight rating and a price target of $43.00, highlighting the potential of the company’s telitacicept ...
Investing.com - JPMorgan initiated coverage on Vor Biopharma, Inc. (NASDAQ:VOR) with an Overweight rating and a $43.00 price target, citing the potential of its telitacicept drug. The target ...
The airplane was cleared to VOR/DME approach to Runway 03 at the Ventspils International airport, Latvia. At the altitude approx 270 ft EGPWS (Enhanced Groung Proximity Warning System) ,,Too Low Flap’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback